The Good News
Policy & Ethics
Where science meets society: regulatory decisions, research ethics, public health policy, and the debates around how scientific knowledge is applied, funded, and communicated.
Once, an HIV/AIDS diagnosis meant virtually certain death. [1] That was before Gilead Pharmaceuticals developed the drug tenofovir in two “prodrug” forms [2], tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF).
Medicare Advantage (MA) accounts for an increasing share of overall Medicare coverage. The privatized program now serves 54% of eligible beneficiaries, and why not?
Join us on the Science Dispatch podcast as we discuss:
The American College of Lifestyle Medicine (ACLM) recently launched Project Remission, which is dedicated to the idea that chronic diseases, such as hypertension, type 2 diabetes, and obesity, are not inevitably progressive and can
In a move critics are already calling political theater, President Donald J. Trump, joined by senior administration officials including HHS Secretary Kennedy, announced an executive order recommending a new vaccine schedule.
As summer rolls on, we're making headlines, covering everything from AI-generated health videos featuring fake doctors to the latest absurdities in America's war on pain patients.
In the days since Dr. Anthony Fauci’s Senate hearing and the accompanying 1,100-page document dump, we’ve learned some revealing facts about the man who spearheaded America’s pandemic response.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
